No paralogue variants have been mapped to residue 2160 for RYR1.
RYR1 | GLGELLRALPRAYTISPSSVEDTMSLLECL>G<QIRSLLIVQMGPQEENLMIQSIGNIMNNKV | 2190 |
RYR2 | GIGGLVRALPKTYTINGVSVEDTINLLASL>G<QIRSLLSVRMGKEEEKLMIRGLGDIMNNKV | 2154 |
RYR3 | SIGELLQALRKTYTISHTSVSDTINLLAAL>G<QIRSLLSVRMGKEEELLMINGLGDIMNNKV | 2052 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.G2160S | c.6478G>A | Other Myopathy | rs143398211 | SIFT: Polyphen: | |
Reports | Other Myopathy | The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility. Clin Genet. 2009 76(6):564-8. 19807743 | |||
Unknown | Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015 25(3):305-15. doi: 10.1101/gr.183483.114. 25637381 | ||||
Other Myopathy | Identification of Medically Actionable Secondary Findings in the 1000 Genomes. PLoS One. 2015 10(9):e0135193. doi: 10.1371/journal.pone.0135193. 26332594 | ||||
p.G2160R | c.6478G>C | Putative Benign | SIFT: Polyphen: |